Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
210
datasets available to search
ShareScore release 0.9.0
Dataset results
210 results for “Ebola”
Single-cell profiling of Ebola virus infection in vivo reveals viral and host transcriptional dynamics (InVivo scRNA-seq)
GEO Series GSE158442. Macaca mulatta. 82 samples. Type: Expression profiling by high throughput sequencing.
MicroRNA expression profiling of one rhesus macaque at day 0 and day 7 post-exposure to aerosolized Ebola virus
GEO Series GSE64579. Macaca mulatta; synthetic construct. 6 samples. Type: Expression profiling by RT-PCR.
A systems approach reveals MAVS signaling in myeloid cells as critical in resistance to Ebola virus in murine models of infection
GEO Series GSE83309. Mus musculus. 64 samples. Type: Expression profiling by array.
Identification of early gene expression profiles governing long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo
GEO Series GSE232633. Homo sapiens. 344 samples. Type: Expression profiling by high throughput sequencing.
IHH microRNA response to genetically-reconstructed Zaire Ebola viruses [miRNA]
GEO Series GSE69943. Homo sapiens. 15 samples. Type: Non-coding RNA profiling by array.
Ebola virus glycoprotein variant with increased infectivity for human cells dominated the 2013-2016 outbreak
GEO Series GSE84865. Homo sapiens. 26 samples. Type: Expression profiling by high throughput sequencing.
An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola
ClinicalTrials.gov study NCT03428347. IPD Sharing: NO. Countries: 1. Publications: 0.
Prophylaxis Vaccine Antibodies Ebola
ClinicalTrials.gov study NCT04822376. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination with the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC
ClinicalTrials.gov study NCT06126822. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
ClinicalTrials.gov study NCT02325050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
ClinicalTrials.gov study NCT01353027. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV
ClinicalTrials.gov study NCT02495246. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus Disease
ClinicalTrials.gov study NCT04815174. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III
ClinicalTrials.gov study NCT05494801. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon
ClinicalTrials.gov study NCT05130398. IPD Sharing: YES. Countries: 1. Publications: 0.
Immunology of Ebola Vaccine
ClinicalTrials.gov study NCT06100913. IPD Sharing: YES. Countries: 1. Publications: 0.
Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP
ClinicalTrials.gov study NCT05067166. IPD Sharing: Not stated. Countries: 0. Publications: 11.
Surveillance of Vaccine-induced Immunity Against Ebola in Previously Vaccinated Health Care Workers
ClinicalTrials.gov study NCT05313139. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects
ClinicalTrials.gov study NCT02370589. IPD Sharing: Not stated. Countries: 1. Publications: 0.
REVIVE (Response to the Ebola Virus Vaccine)
ClinicalTrials.gov study NCT05992480. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.